These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 18613071

  • 41. Predictive model of blood-brain barrier penetration of organic compounds.
    Ma XL, Chen C, Yang J.
    Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
    [Abstract] [Full Text] [Related]

  • 42. Application of MOLMAP approach for QSAR modeling of various biological activities using substituent electronic descriptors.
    Hemmateenejad B, Mehdipour AR, Miri R, Shamsipur M.
    J Comput Chem; 2009 Oct; 30(13):2001-9. PubMed ID: 19130500
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD, Hamza A, Liu J, Zhan CG.
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [Abstract] [Full Text] [Related]

  • 45. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F, Horvath D.
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
    Nair PC, Sobhia ME.
    Eur J Med Chem; 2008 Feb; 43(2):293-9. PubMed ID: 17513019
    [Abstract] [Full Text] [Related]

  • 50. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
    Nataraja Sekhar Y, Ravikumar M, Ravi Shashi Nayana M, Mallena SC, Kishore Kumar M.
    Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
    [Abstract] [Full Text] [Related]

  • 51. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets.
    Gedeck P, Rohde B, Bartels C.
    J Chem Inf Model; 2006 May; 46(5):1924-36. PubMed ID: 16995723
    [Abstract] [Full Text] [Related]

  • 52. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
    Chen KX, Xie HY, Li ZG, Gao JR.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5381-6. PubMed ID: 18835162
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
    Li ZS, Sun JY, Liang GZ, Lu FL, Zhu WP, Zhang MJ, Zhang Y, Yang SB, Shu M, Chen GH, Lu TT.
    Chem Biol Drug Des; 2009 Feb 15; 73(2):236-43. PubMed ID: 19207426
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. 2D QSAR of PPARgamma agonist binding and transactivation.
    Rücker C, Scarsi M, Meringer M.
    Bioorg Med Chem; 2006 Aug 01; 14(15):5178-95. PubMed ID: 16650995
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Predictive QSAR modeling of phosphodiesterase 4 inhibitors.
    Kovalishyn V, Tanchuk V, Charochkina L, Semenuta I, Prokopenko V.
    J Mol Graph Model; 2012 Feb 01; 32():32-8. PubMed ID: 22023934
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.